Rare disease drug development is getting a boost from new funding models and a growing group of smaller biotech buyers.
$BCRX
Price history, market instrument context, member research, and related headlines in one place.
BCRX key statistics
NasdaqGSUSD
52-week range
$6.2336%$11.22
Latest session $7.95–$8.23BioCryst Pharmaceuticals, Inc. (BCRX) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $8.02, down $0.03 (0.37%) from the previous close of $8.05. It has traded between $7.95 and $8.23 in the latest session. Over the past year it has ranged from $6.23 to $11.22, leaving it in the lower half of its 52-week range (36%). Reported volume for the session was 4.5M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
BioCryst (BCRX) Q2 2026 Earnings Call Transcript — See source for full details.
Moby summary of BioCryst Pharmaceuticals, Inc.
Biocryst outlines $690M-$715M 2026 total revenue guidance with operating costs at $420M-$440M — See source for full details.
BioCryst earnings beat by $0.14, revenue topped estimates — See source for full details.
BioCryst earnings on deck: Can Orladeyo sustain momentum? — See source for full details.
Loading $BCRX research…